000 01560 a2200457 4500
005 20250518012746.0
264 0 _c20200220
008 202002s 0 0 eng d
022 _a1878-7568
024 7 _a10.1016/j.actbio.2018.12.007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGuo, Xue-Ling
245 0 0 _aCo-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
_h[electronic resource]
260 _bActa biomaterialia
_c01 2019
300 _a367-377 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xchemistry
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCisplatin
_xchemistry
650 0 4 _aDendrimers
_xchemistry
650 0 4 _aDoxorubicin
_xchemistry
650 0 4 _aDrug Carriers
_xchemistry
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMCF-7 Cells
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMice, Nude
650 0 4 _aNanoparticles
_xchemistry
650 0 4 _aPolyamines
_xchemistry
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aKang, Xiao-Xuan
700 1 _aWang, Yue-Qi
700 1 _aZhang, Xiao-Jie
700 1 _aLi, Chang-Jian
700 1 _aLiu, Yang
700 1 _aDu, Li-Bo
773 0 _tActa biomaterialia
_gvol. 84
_gp. 367-377
856 4 0 _uhttps://doi.org/10.1016/j.actbio.2018.12.007
_zAvailable from publisher's website
999 _c29141905
_d29141905